A detailed history of Bridges Investment Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bridges Investment Management Inc holds 14,600 shares of BMY stock, worth $717,298. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,600
Previous 12,629 15.61%
Holding current value
$717,298
Previous $684,000 11.4%
% of portfolio
0.01%
Previous 0.02%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$40.25 - $52.99 $79,332 - $104,443
1,971 Added 15.61%
14,600 $606,000
Q1 2024

Apr 25, 2024

SELL
$47.98 - $54.4 $4,798 - $5,440
-100 Reduced 0.79%
12,629 $684,000
Q2 2023

Jul 07, 2023

SELL
$63.71 - $70.74 $43,641 - $48,456
-685 Reduced 5.11%
12,729 $814,000
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $140,384 - $166,234
-2,050 Reduced 13.26%
13,414 $965,000
Q3 2022

Oct 21, 2022

SELL
$0.13 - $76.84 $130 - $76,840
-1,000 Reduced 6.07%
15,464 $1.1 Million
Q1 2022

Apr 08, 2022

SELL
$61.48 - $73.72 $86,072 - $103,208
-1,400 Reduced 7.84%
16,464 $1.2 Million
Q4 2021

Feb 01, 2022

SELL
$53.63 - $62.52 $305,154 - $355,738
-5,690 Reduced 24.16%
17,864 $1.11 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $11,715 - $13,723
-198 Reduced 0.83%
23,554 $1.39 Million
Q2 2021

Jul 19, 2021

SELL
$61.91 - $67.42 $15,477 - $16,855
-250 Reduced 1.04%
23,752 $1.59 Million
Q1 2021

May 05, 2021

SELL
$59.34 - $66.74 $57,144 - $64,270
-963 Reduced 3.86%
24,002 $1.52 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $177,088 - $200,673
-3,067 Reduced 10.94%
24,965 $1.55 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $39,511 - $43,784
-688 Reduced 2.4%
28,032 $1.69 Million
Q2 2020

Aug 10, 2020

SELL
$54.82 - $64.09 $134,034 - $156,700
-2,445 Reduced 7.85%
28,720 $1.69 Million
Q1 2020

May 12, 2020

SELL
$46.4 - $67.43 $639,438 - $929,252
-13,781 Reduced 30.66%
31,165 $1.74 Million
Q4 2019

Feb 18, 2020

SELL
$49.21 - $64.19 $585,500 - $763,732
-11,898 Reduced 20.93%
44,946 $2.89 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $573,588 - $680,071
13,411 Added 30.88%
56,844 $2.88 Million
Q2 2019

Aug 07, 2019

BUY
$44.62 - $49.34 $466,591 - $515,948
10,457 Added 31.71%
43,433 $1.97 Million
Q1 2019

May 01, 2019

SELL
$45.12 - $53.8 $18,769 - $22,380
-416 Reduced 1.25%
32,976 $1.57 Million
Q4 2018

Feb 11, 2019

BUY
$48.76 - $63.23 $114,634 - $148,653
2,351 Added 7.57%
33,392 $1.74 Million
Q3 2018

Nov 15, 2018

SELL
$55.19 - $62.25 $578,556 - $652,566
-10,483 Reduced 25.25%
31,041 $1.93 Million
Q2 2018

Aug 15, 2018

BUY
$50.53 - $62.98 $116,976 - $145,798
2,315 Added 5.9%
41,524 $2.3 Million
Q1 2018

Apr 25, 2018

BUY
$59.92 - $68.98 $1.14 Million - $1.32 Million
19,095 Added 94.93%
39,209 $2.48 Million
Q4 2017

Feb 09, 2018

BUY
$59.94 - $65.35 $20,979 - $22,872
350 Added 1.77%
20,114 $1.23 Million
Q3 2017

Oct 05, 2017

BUY
$55.23 - $63.74 $306,526 - $353,757
5,550 Added 39.05%
19,764 $1.26 Million
Q3 2017

Oct 02, 2017

BUY
$55.23 - $63.74 $785,039 - $906,000
14,214
14,214 $906,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $104B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bridges Investment Management Inc Portfolio

Follow Bridges Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridges Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bridges Investment Management Inc with notifications on news.